“…Acidity is a unique hallmark of the tumor microenvironment. − Many pH-sensitive nanomedicines were designed and prepared to respond to the acidic tumor microenvironment promoting antitumor efficiency. − Inorganic nanomaterials, which possess a diverse range of structure, composition, morphology, and physicochemical properties have been used in cancer treatment and diagnosis as delivery carriers. − Recently, various metal oxides or calcium-based nanomaterials have been widely used as pH-sensitive inorganic nanomaterials. − It has been reported that ZnO NPs could be used as pH-responsive drug carriers, which possess pH-triggered drug release characteristics displaying a response to acid and a rapid dissolution to Zn 2+ at pH <5.5, especially in lysosomes used for intracellular drug delivery platforms. − The intracellular Zn 2+ produced by ZnO NPs has cytotoxic effects in tumor cells. , In addition, ZnO NPs could significantly induce the generation of ROS in tumor cells. − In particular, ZnO NPs can make full utilization of disproportional reaction, Haber–Weiss reaction, or Fenton reaction to compensate for O 2 -depletion, thus greatly improving the therapeutic efficacy against hypoxic tumors . ZnO NPs also have good optical properties and high stability to be a promising candidate for bioimaging. , ZnO NPs could be used to in situ upconvert NIR to visible light through the second harmonic generation (SHG) mechanism for tumor imaging. , Recently, we designed an H 2 O 2 -triggered intelligent photodynamic therapy (PDT) nano delivery system, LCL/ZnO, that could selectively regulate the tumor-derived endothelial cells (TECs) and specifically kill tumor cells by producing different singlet oxygen ( 1 O 2 ) in response to different H 2 O 2 gradients in TECs and tumor cells .…”